+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Infertility (Testing and Treatment) Market 2019-2027

  • ID: 4774263
  • Report
  • Region: North America, United States
  • 130 pages
  • Triton Market Research
UP TO OFF
until Jan 31st 2020
1 of 3

FEATURED COMPANIES

  • Andrology Solutions
  • Esco Micro Pte. Ltd.
  • Genea
  • Irvine Scientific
  • Origio
  • Progyny
  • MORE
Market Outlook

The North America infertility (testing and treatment) market is expected to grow during the forecast years 2018-2026 at a CAGR of 6.83% in terms of revenue.

The countries of Canada and the US together form the infertility (testing and treatment) market in North America. The North American market is driven by the technological advancements and the wide availability of IVF reimbursements.

The market includes regions such as the US, Canada. The fertility services market in the US is anticipated to grow at a steady rate throughout the forecast period. The Center for Disease Control and Prevention (CDC) estimates that even though the use of assisted reproductive techniques is still relatively uncommon as compared to the potential demand, its adoption has doubled over the past decade. Currently, approximately 1.6% of all babies born in the US every year are conceived through ART.

Although the use of assisted reproductive technology in Canada is growing, only 15% of the affected population is opting for IVF treatments due to its high cost. Others are choosing cheaper treatments resulting in the increasing rate of multiple pregnancies. The use of IVF and other ARTs is increasing, especially in female infertility cases. Infertility rate in Canadian women is increasing, and the major reasons are age, obesity, alcohol use and sexually transmitted infections. It is estimated that around 20% of couples living in Canada suffer from infertility-related issues to some extent. The cost of IVF treatment widely varies across the country. In Canada, IVF is not covered by provincial health plans. In 2004, the federal government enacted legislation to regulate assisted reproduction. The Assisted Human Reproduction Act, which governs the clinical and research activities of medically assisted human reproduction, identifies activities that are either prohibited or are subject to regulation. In 2006, Assisted Human Reproduction Canada was established to implement and enforce the Act’s principles.

Competitive Outlook

The prominent players in the market are Merck, Ferring Pharmaceuticals, Andrology Solutions, Genea, Origio, Progyny, OvaScience, Irvine Scientific, Halotech DNA, Endo Pharmaceuticals, Vitrolife AB, The Cooper Companies, Inc., Esco Micro Pte. Ltd., Thermo Fisher Scientific Inc. and Quest Diagnostic.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Andrology Solutions
  • Esco Micro Pte. Ltd.
  • Genea
  • Irvine Scientific
  • Origio
  • Progyny
  • MORE
1. Infertility (Testing And Treatment) Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Key Insights
2.2.1. Ivf Dominates the Female Treatment Market
2.2.2. Oxidative Stress Analysis is the Fastest Growing Male Infertility Testing Market
2.3. Porter’s Five Force Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute
2.3.3. Bargaining Power of Buyers
2.3.4. Bargaining Power of Suppliers
2.3.5. Intensity of Competitive Rivalry
2.4. Key Impact Analysis
2.4.1. Treatment Options
2.4.2. Quality of Medical Procedures
2.4.3. Price of Treatments
2.4.4. Shift Towards Medical Tourism
2.4.5. Reimbursement
2.5. Market Attractiveness Index
2.6. Vendor Scorecard
2.7. Industry Components
2.7.1. Raw Material Procurement
2.7.2. Manufacturing
2.7.3. Supply LoGIStics
2.7.4. Distribution Channels
2.7.5. End-Users
2.8. Regulatory Framework
2.9. Market Drivers
2.9.1. Rise in Infertility And Treatment Awareness
2.9.2. Medical Tourism in Fertility Treatments
2.9.3. Surrogacy Laws Are Getting More Defined
2.9.4. Healthcare Advances Have Fine-Tuned Fertility Treatment
2.9.5. Increasing Effectiveness of Treatments
2.9.6. Healthier Donor Eggs
2.9.7. Introduction of New Testing Devices
2.10. Market Restraints
2.10.1. Treatment Procedure Out of Reach For Many Due to High Costs
2.10.2. Country-Wise Regulatory Issues
2.11. Market Opportunities
2.11.1. Reducing the Cost of Treatment to Make It More Accessible
2.11.2. Ivf Attracting Investments From Private Equity Investors
2.11.3. Diy Testing Increasing Access And Reducing Cost
2.12. Market Challenges
2.12.1. Infertility Considered a Social Taboo Amongst Men
2.12.2. Perils of Multiple Pregnancies
2.12.3. Traditional Treatments Used Widely As An Alternative For Infertility Treatments

3. Infertility (Testing And Treatment) Market Outlook - By Gender
3.1. Male Gender
3.1.1. Testing
3.1.1.1. Dna Fragmentation
3.1.1.2. Oxidative Stress Analysis
3.1.1.3. Sperm Penetration Assay
3.1.1.4. Computer-Assisted Semen Analysis (Casa)
3.1.1.5. Sperm Agglutination
3.1.1.6. Microscopic Examination
3.1.1.7. Others
3.1.2. Treatment
3.1.2.1. Vasovasostomy And Vasoepididymostomy (Vasectomy Reversal)
3.1.2.2. Sperm Retrieval Treatment
3.1.2.3. Microsurgical Sperm Aspiration (Mesa)
3.1.2.4. Testicular Sperm Extraction (Tese)
3.1.2.5. Varicocele Repairs
3.1.2.6. Assisted Reproductive Techniques (Art)
3.1.2.7. Intrauterine Insemination (Iui)
3.1.2.8. In-Vitro Fertilization (Ivf)
3.1.2.9. Intracytoplasmic Sperm Injection (Icsi)
3.2. Female Gender
3.2.1. Female Infertility Testing
3.2.1.1. Ovulation Testing
3.2.1.2. Hysterosalpingography
3.2.1.3. Laparoscopy
3.2.1.4. Transvaginal Ultrasound
3.2.1.5. Ovarian Reserve Testing
3.2.1.6. Hormonal Level Testing
3.2.1.7. Others
3.2.2. Treatment
3.2.2.1. In-Vitro Fertilization
3.2.2.2. Intrauterine Insemination (Iui)
3.2.2.3. Drug And Hormone Therapies

4. Infertility (Testing And Treatment) Market Outlook - By End-Use
4.1. Fertility Clinics
4.2. Hospitals
4.3. Surgical Centers
4.4. Clinical Research Institutes

5. Infertility (Testing And Treatment) Market - Regional Outlook
5.1. North America
5.1.1. Country Analysis
5.1.1.1. United States
5.1.1.2. Canada

6. Competitive Landscape
6.1. Andrology Solutions
6.2. Endo Pharmaceuticals
6.3. Progyny
6.4. Ferring Pharmaceuticals
6.5. Genea
6.6. Halotech Dna
6.7. Irvine Scientific
6.8. Merck
6.9. Origio
6.10. Ovascience
6.11. Vitrolife Ab
6.12. Thermo Fisher Scientific, Inc.
6.13. the Cooper Companies, Inc.
6.14. Quest Diagnostic
6.15. Esco Micro Pte. Ltd.

7. Research Methodology & Scope
7.1. Research Scope & Deliverables
7.1.1. Objectives of Study
7.2. Sources of Data
7.2.1. Primary Data Sources
7.2.2. Secondary Data Sources
7.3. Research Methodology
7.3.1. Evaluation of Proposed Market
7.3.2. Identification of Data Sources
7.3.3. Assessment of Market Determinants
7.3.4. Data Collection
7.3.5. Data Validation & Analysis

List of Tables
Table 1: North America Infertility (Testing And Treatment) Market, By Country, 2019-2027 (In $ Million)
Table 2: Market Attractiveness Index
Table 3: Vendor Scorecard
Table 4: Regulatory Framework
Table 5: Average Cost Comparison of Infertility Treatments
Table 6: North America Infertility (Testing And Treatment) Market, By Country, 2019-2027 (In $ Million)
Table 7: North America Infertility (Testing And Treatment) Market, By Gender, 2019-2027 (In $ Million)
Table 8: North America Infertility (Testing And Treatment) Market, By End-Use, 2019-2027 (In $ Million)
Table 9: North America Infertility (Testing And Treatment) Market, By Male Infertility Testing, 2019-2027 (In $ Million)
Table 10: North America Infertility (Testing And Treatment) Market, By Female Gender, 2019-2027 (In $ Million)
Table 11: North America Infertility (Testing And Treatment) Market, By Female Infertility Testing, 2019-2027 (In $ Million)
Table 12: North America Infertility (Testing And Treatment) Market, By Gender, 2019-2027 (In $ Million)
Table 13: Success of Assisted Reproductive Technology (Art) Using Donor Eggs in the Us in 2013
Table 14: Costs For Infertility Treatments in the Us 2015
Table 15: Cost of Ivf & Icsi Treatment, Canada 2014

List of Figures
Figure 1: North America Infertility (Testing And Treatment) Market, By End-User, 2018 & 2027 (In %)
Figure 2: Porter’s Five Force Analysis
Figure 3: Key Buying Impact Analysis
Figure 4: Industry Components
Figure 5: Major Fertility Treatment Destination Ranking
Figure 6: Clinical Algorithm For the Evaluation of Infertile Woman
Figure 7: Rate of Multiple Deliveries
Figure 8: North America Infertility (Testing And Treatment) Market, By Male Gender, 2019-2027 (In $ Million)
Figure 9: North America Infertility (Testing And Treatment) Market, By Testing, 2019-2027 (In $ Million)
Figure 10: North America Infertility (Testing And Treatment) Market, By Dna Fragmentation, 2019-2027 (In $ Million)
Figure 11: Causes of Sperm Dna Fragmentation
Figure 12: North America Infertility (Testing And Treatment) Market, By Oxidative Stress Analysis, 2019-2027 (In $ Million)
Figure 13: North America Infertility (Testing And Treatment) Market, By Sperm Penetration Assay, 2019-2027 (In $ Million)
Figure 14: North America Infertility (Testing And Treatment) Market, By Computer-Assisted Semen Analysis, 2019-2027 (In $ Million)
Figure 15: North America Infertility (Testing And Treatment) Market, By Sperm Agglutination, 2019-2027 (In $ Million)
Figure 16: North America Infertility (Testing And Treatment) Market, By Microscopic Examination, 2019-2027 (In $ Million)
Figure 17: North America Infertility (Testing And Treatment) Market, By Others, 2019-2027 (In $ Million)
Figure 18: North America Infertility (Testing And Treatment) Market, By Treatment, 2019-2027 (In $ Million)
Figure 19: North America Infertility (Testing And Treatment) Market, By Female Gender, 2019-2027 (In $ Million)
Figure 20: North America Infertility (Testing And Treatment) Market, By Female Infertility Testing, 2019-2027 (In $ Million)
Figure 21: North America Infertility (Testing And Treatment) Market, By Ovulation Testing, 2019-2027 (In $ Million)
Figure 22: North America Infertility (Testing And Treatment) Market, By Hysterosalpingography, 2019-2027 (In $ Million)
Figure 23: North America Infertility (Testing And Treatment) Market, By Laparoscopy, 2019-2027 (In $ Million)
Figure 24: North America Infertility (Testing And Treatment) Market, By Transvaginal Ultrasound, 2019-2027 (In $ Million)
Figure 25: North America Infertility (Testing And Treatment) Market, By Ovarian Reserve Testing, 2019-2027 (In $ Million)
Figure 26: North America Infertility (Testing And Treatment) Market, By Hormonal Level Testing, 2019-2027 (In $ Million)
Figure 27: North America Infertility (Testing And Treatment) Market, By Others, 2019-2027 (In $ Million)
Figure 28: North America Infertility (Testing And Treatment) Market, By Female Infertility Treatment, 2019-2027 (In $ Million)
Figure 29: North America Infertility (Testing And Treatment) Market, By Fertility Clinics, 2019-2027 (In $ Million)
Figure 30: North America Infertility (Testing And Treatment) Market, By Hospitals, 2019-2027 (In $ Million)
Figure 31: North America Infertility (Testing And Treatment) Market, By Surgical Centers, 2019-2027 (In $ Million)
Figure 32: North America Infertility (Testing And Treatment) Market, By Clinical Research Institutes, 2019-2027 (In $ Million)
Figure 33: North America Infertility (Testing And Treatment) Market, Regional Outlook, 2018 & 2027 (In %)
Figure 34: United States Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 35: Canada Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Andrology Solutions
  • Endo Pharmaceuticals
  • Progyny
  • Ferring Pharmaceuticals
  • Genea
  • Halotech Dna
  • Irvine Scientific
  • Merck
  • Origio
  • Ovascience
  • Vitrolife AB
  • Thermo Fisher Scientific, Inc.
  • The Cooper Companies, Inc.
  • Quest Diagnostic
  • Esco Micro Pte. Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll